Breakthrough ALS study launches as drug aims to slow disease progression
Fox News - Breaking News Updates | Latest News Headlines | Phot…
April 3, 2026
The PREVAiLS study, believed to be the only recruiting phase 3 ALS trial, aims to slow disease progression and preserve function in early-stage patients.
Discussion in the ATmosphere